vimarsana.com
Home
Live Updates
Zydus Receives Final Approval From The USFDA For Diclofenac
Zydus Receives Final Approval From The USFDA For Diclofenac
Zydus Receives Final Approval From The USFDA For Diclofenac Sodium And Misoprostol Delayed Release Tablets
Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States (IQVIA MAT Mar. 2023).
Related Keywords
Ahmedabad ,
Gujarat ,
India ,
United States ,
Moraiya ,
,
Drug Administration ,
Zydus Lifesciences ,
Zydus Lifesciences Limited ,
United States Food ,
Diclofenac Sodium ,
Misoprostol Delayed Release Tablets ,
Delayed Release Tablets ,